4/A//SEC Filing
Culwell Kelly 4/A
Accession 0001618835-18-000125
CIK 0001618835other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 12:49 PM ET
Size
5.9 KB
Accession
0001618835-18-000125
Insider Transaction Report
Form 4/AAmended
Culwell Kelly
Chief Medical Officer
Transactions
- Award
Common Stock
2018-11-28+100,000→ 100,000 totalExercise: $3.45Exp: 2028-11-28→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]The original Form 4, filed on November 29, 2018, is being amended to update the number of shares reported in Column 5(A) and Column 7 of Table II.
- [F2]The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from November 28, 2018.
Documents
Issuer
Evofem Biosciences, Inc.
CIK 0001618835
Entity typeother
Related Parties
1- filerCIK 0001726183
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 12:49 PM ET
- Size
- 5.9 KB